down arrow

Morepen Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
50.25
2.13 (4.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 31.04 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

49.5050.79

52 Week

41.66100.80
Valuation
Technical
Day's Volume

CASH

31.04 lacs (-37.16%) Volume

Shareholding (Dec 2024)

FII

2.22%

Held by 44 FIIs

DII

1.65%

Held by 6 DIIs

Promoter

35.65%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • PBT LESS OI(Q) At Rs 29.87 cr has Fallen at -27.0 %
  • PAT(Q) At Rs 26.69 cr has Fallen at -18.7 %
  • PBDIT(Q) Lowest at Rs 35.51 cr.
2

Stock is technically in a Bearish range

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,753 Cr (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

11.82%

stock-summary
Price to Book

2.37

Revenue and Profits (1 Year):
Net Sales:
453 Cr
(Quarterly Results - Dec 2024)
Net Profit:
27 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-42.61%
0%
-42.61%
1 Year
8.3%
0%
8.3%
2 Years
93.72%
0%
93.72%
3 Years
12.17%
0%
12.17%
4 Years
29.68%
0%
29.68%
5 Years
194.55%
0%
194.55%

Morepen Labs. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.38%
EBIT Growth (5y)
37.62%
EBIT to Interest (avg)
20.67
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.30
Tax Ratio
26.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.87%
ROCE (avg)
16.10%
ROE (avg)
14.15%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
33
Price to Book Value
2.37
EV to EBIT
15.71
EV to EBITDA
13.83
EV to Capital Employed
2.59
EV to Sales
1.40
PEG Ratio
0.38
Dividend Yield
NA
ROCE (Latest)
17.65%
ROE (Latest)
11.82%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 44 FIIs (2.22%)

Promoter with highest holding

Scope Credits And Financial Services Pvt. Ltd. (2.84%)

Highest Public shareholder

Pinfold Overseas Limited (7.03%)

Individual Investors Holdings

48.35%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 3.44% vs -3.84% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -23.41% vs -3.65% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "452.78",
          "val2": "437.73",
          "chgp": "3.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "35.51",
          "val2": "44.08",
          "chgp": "-19.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.34",
          "val2": "1.18",
          "chgp": "13.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.69",
          "val2": "34.85",
          "chgp": "-23.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.84%",
          "val2": "10.07%",
          "chgp": "-2.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 8.52% vs 16.65% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 97.88% vs 67.40% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "892.94",
          "val2": "822.80",
          "chgp": "8.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "95.68",
          "val2": "59.67",
          "chgp": "60.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.33",
          "val2": "0.74",
          "chgp": "214.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "71.02",
          "val2": "35.89",
          "chgp": "97.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.72%",
          "val2": "7.25%",
          "chgp": "3.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.18% vs 20.26% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 43.95% vs 123.07% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,345.72",
          "val2": "1,267.35",
          "chgp": "6.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.19",
          "val2": "110.24",
          "chgp": "19.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.67",
          "val2": "2.91",
          "chgp": "26.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "97.71",
          "val2": "67.88",
          "chgp": "43.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.75%",
          "val2": "8.70%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.25% vs -8.36% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 148.60% vs -61.96% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,690.43",
          "val2": "1,417.53",
          "chgp": "19.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "158.62",
          "val2": "79.53",
          "chgp": "99.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.71",
          "val2": "1.98",
          "chgp": "87.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "96.16",
          "val2": "38.68",
          "chgp": "148.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.38%",
          "val2": "5.61%",
          "chgp": "3.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
452.78
437.73
3.44%
Operating Profit (PBDIT) excl Other Income
35.51
44.08
-19.44%
Interest
1.34
1.18
13.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.69
34.85
-23.41%
Operating Profit Margin (Excl OI)
7.84%
10.07%
-2.23%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 3.44% vs -3.84% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -23.41% vs -3.65% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
892.94
822.80
8.52%
Operating Profit (PBDIT) excl Other Income
95.68
59.67
60.35%
Interest
2.33
0.74
214.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
71.02
35.89
97.88%
Operating Profit Margin (Excl OI)
10.72%
7.25%
3.47%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 8.52% vs 16.65% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 97.88% vs 67.40% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,345.72
1,267.35
6.18%
Operating Profit (PBDIT) excl Other Income
131.19
110.24
19.00%
Interest
3.67
2.91
26.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
97.71
67.88
43.95%
Operating Profit Margin (Excl OI)
9.75%
8.70%
1.05%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.18% vs 20.26% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 43.95% vs 123.07% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,690.43
1,417.53
19.25%
Operating Profit (PBDIT) excl Other Income
158.62
79.53
99.45%
Interest
3.71
1.98
87.37%
Exceptional Items
0.00
0.00
Consolidate Net Profit
96.16
38.68
148.60%
Operating Profit Margin (Excl OI)
9.38%
5.61%
3.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.25% vs -8.36% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 148.60% vs -61.96% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Morepen Laboratories Ltd stock-summary
stock-summary
Morepen Laboratories Ltd
Small Cap
Pharmaceuticals & Drugs
Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
Company Coordinates stock-summary
Company Details
Morepen Village, Nalagarh Road Near Baddi Solan Himachal Pradesh : 173205
stock-summary
Tel: 91-01795-276201-03
stock-summary
http://www.morepen.com
stock-summary
investors@morepen.com
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."